Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pillar5 Pharma Passes FDA Inspection | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pillar5 Pharma Passes FDA Inspection

To manufacture a solid dose product for a client

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pillar5 Pharma Inc. has successfully passed a cGMP and pre-approval inspection (PAI) for an NDA by the FDA to manufacture a solid dose product for a client. A full inspection was performed of the quality, facility and equipment, materials, laboratory, production, packaging and labeling systems, with no 483 observations.
 
“I am very pleased that Pillar5’s high quality standards and expertise were reflected in the outcome of this inspection,” said John Carkner, president and chief executive officer of Pillar5. “This is a significant milestone for our client partnership and brings this important product one step closer to market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics